Hydromadinone

From Wikipedia, the free encyclopedia
Hydromadinone
Hydromadinone.svg
Clinical data
ATC code
  • None
Identifiers
  • 6α-Chloro-17α-hydroxypregn-4-ene-3,20-dione
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC21H29ClO3
Molar mass364.91 g·mol−1
3D model (JSmol)
  • CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H](C4=CC(=O)CC[C@]34C)Cl)C)O
  • InChI=1S/C21H29ClO3/c1-12(23)21(25)9-6-16-14-11-18(22)17-10-13(24)4-7-19(17,2)15(14)5-8-20(16,21)3/h10,14-16,18,25H,4-9,11H2,1-3H3/t14-,15+,16+,18+,19-,20+,21+/m1/s1
  • Key:IMUIZZGKYILUHZ-SCUQKFFVSA-N

Hydromadinone (INN), also known as 6α-chloro-17α-hydroxyprogesterone, is a steroidal progestin of the 17α-hydroxyprogesterone group which was patented in 1967 but was never marketed.[1] The C17α acetate ester of hydromadinone, hydromadinone acetate, also exists, but similarly was never marketed.[1]

See also[]

References[]

  1. ^ a b Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. p. 1037. ISBN 978-0-412-46630-4.
Stub icon

This article about a steroid is a stub. You can help Wikipedia by .

  • v
  • t
Retrieved from ""